Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Herrmann

Showing results (331-340 of 403) with videos related to

Pageof 41
Sort By:
The Lancet. Rheumatology|January 22, 2024
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trialMichaela Koehm, Tanja Rossmanith, Ann C Foldenauer, et al.
Neuroradiology|October 2, 2022
MR imaging profile and histopathological characteristics of tumour vasculature, cell density and proliferation rate define two distinct growth patterns of human brain metastases from lung cancerMakoto Kiyose, Eva Herrmann, Jenny Roesler, et al.
Journal of Gastroenterology and Hepatology|June 22, 2019
Capnography monitoring of non-anesthesiologist provided sedation during percutaneous endoscopic gastrostomy placement: A prospective, controlled, randomized trialJan Peveling-Oberhag, Florian Michael, Andrea Tal, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2023
Clinical characteristics and outcome of Mycobacterium chimaera infections after cardiac surgery: systematic review and meta-analysis of 180 heater-cooler unit-associated casesNils Wetzstein, Thomas A Kohl, Margo Diricks, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2009
Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis BDong Jin Suh, Soon Ho Um, Eva Herrmann, et al.
Journal of Clinical Medicine|January 11, 2024
Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists-Results of the German Prospective RADOA-RegistryJana Last, Eva Herrmann, Ingvild Birschmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 23, 2016
Pretransplant human leukocyte antigen antibodies detected by single-antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor-specific antibodiesRudolf Richter, Caner Süsal, Stefanie Köhler, et al.
Antiviral Therapy|February 5, 2008
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis BMartijn J ter Borg, Bettina E Hansen, Eva Herrmann, et al.
Gastroenterology|July 26, 2011
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeksChristoph Sarrazin, Susanne Schwendy, Bernd Möller, et al.
AIDS (London, England)|May 20, 2011
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapyAlison A Murphy, Eva Herrmann, Anu O Osinusi, et al.
Pageof 41

Showing results (331-340 of 403) with videos related to

Sort By:
Pageof 41
The Lancet. Rheumatology|January 22, 2024
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trialMichaela Koehm, Tanja Rossmanith, Ann C Foldenauer, et al.
Neuroradiology|October 2, 2022
MR imaging profile and histopathological characteristics of tumour vasculature, cell density and proliferation rate define two distinct growth patterns of human brain metastases from lung cancerMakoto Kiyose, Eva Herrmann, Jenny Roesler, et al.
Journal of Gastroenterology and Hepatology|June 22, 2019
Capnography monitoring of non-anesthesiologist provided sedation during percutaneous endoscopic gastrostomy placement: A prospective, controlled, randomized trialJan Peveling-Oberhag, Florian Michael, Andrea Tal, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2023
Clinical characteristics and outcome of Mycobacterium chimaera infections after cardiac surgery: systematic review and meta-analysis of 180 heater-cooler unit-associated casesNils Wetzstein, Thomas A Kohl, Margo Diricks, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2009
Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis BDong Jin Suh, Soon Ho Um, Eva Herrmann, et al.
Journal of Clinical Medicine|January 11, 2024
Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists-Results of the German Prospective RADOA-RegistryJana Last, Eva Herrmann, Ingvild Birschmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 23, 2016
Pretransplant human leukocyte antigen antibodies detected by single-antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor-specific antibodiesRudolf Richter, Caner Süsal, Stefanie Köhler, et al.
Antiviral Therapy|February 5, 2008
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis BMartijn J ter Borg, Bettina E Hansen, Eva Herrmann, et al.
Gastroenterology|July 26, 2011
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeksChristoph Sarrazin, Susanne Schwendy, Bernd Möller, et al.
AIDS (London, England)|May 20, 2011
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapyAlison A Murphy, Eva Herrmann, Anu O Osinusi, et al.
Pageof 41